Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Nicoletta Staropoli

Ricercatori a tempo determinato

Magna Graecia University

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy

Articles (19)

Year:

2026

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (11)

Aurelio Seidita

Assistant Professor

University of Palermo

ITALY

View details

Claudia Martinelli

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Mario Cannataro

Full Professor

Università degli Studi Mediterranea di Reggio Calabria

ITALY

View details

Francesca Scionti

Senior Research Technologist

Magna Graecia University

ITALY

View details

Gaetano Bertino

Associate Professor

University of Catania

ITALY

View details

Daniele Caracciolo

Associate Professor

Magna Graecia University

ITALY

View details

Giuseppe Agapito

Magna Graecia University

ITALY

View details

Francesca Di Gaudio

Ricercatori

University of Palermo

ITALY

View details

Lydia Giannitrapani

University of Palermo

ITALY

View details

Pierfrancesco Tassone

Professor of Medical Oncology

Università degli Studi Mediterranea di Reggio Calabria

ITALY

View details

Gian Pietro Emerenziani

Professore Associato di Metodi e Didattiche delle Attività Motorie

Università degli Studi Mediterranea di Reggio Calabria

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nicoletta Staropoli

Research Interests

Make your next move.

Explore related searches

Articles (19)

Does Time Heal All Wounds? Alterations in Upper Limb Range of Motion in Breast Cancer Survivors After Recent vs. Non-Recent Surgery: A Cross-Sectional Study

Bioinformatic challenges for pharmacogenomic study: tools for genomic data analysis

Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma

Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis

Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience

Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity

Why Do You Treat pCR Patient With Pertuzumab and Trastuzumab?

Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC)

Gut Microbiota a Novel Source of Biomarkers for Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation

The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis

UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma

First-line systemic treatment for hepatocellular carcinoma: A systematic review and network meta-analysis

The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas

Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study

A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer

Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity

Prevalence of Non-erosive Esophageal Phenotypes in Children: A European Multicenter Study

Risk-Based Therapeutic Strategies for HER2-Positive Early Breast Cancer: A Consensus Paper

Collaborators (11)

Aurelio Seidita

Claudia Martinelli

Mario Cannataro

Francesca Scionti

Gaetano Bertino

Daniele Caracciolo

Giuseppe Agapito

Francesca Di Gaudio

Lydia Giannitrapani

Pierfrancesco Tassone

Gian Pietro Emerenziani

Make your next move.